Scientist Illegally Jailed For Refusing to Refute Documentation Revealing the Dangers of Vaccines - Dr. Judy Mikovits and the Book ~ Plague!

QuantumJudy.JPG

Dr. Judy A. Mikovits earned a BA in Chemistry with a specialization in biology from the University of Virginia in 1980 and a PhD in biochemistry and molecular biology from George Washington University in 1992.

Upon graduation from UVA, she went directly to the National Cancer Institute in Frederick Maryland where she developed purification methods for Interferon alpha. It was this Interferon which was used in the first immune therapy treatment for hairy cell leukemia in 1986.  In 1986-7, prior to enrolling in graduate school. she went to Upjohn Pharmaceuticals in Kalamazoo Michigan to develop production methods to insure biological materials manufactured using human blood products were free of contamination from HIV-1.  Her PhD thesis defense entitled  “Negative Regulation of HIV Expression in Monocytes” changed the paradigm for therapeutic treatment of HIV. For this work, she was awarded the graduate student of the year in 1991.  In her thirty-five-year quest to understand and develop therapies for chronic diseases, she has co-authored seminal papers culminating at least a decade of research in each of four fields: immunology, natural products chemistry, epigenetics, and HIV/AIDs drug development.  

In 2006, Dr.  Mikovits became attracted to the plight of families with neuroimmune diseases including ME/CFS and Autism and was primarily responsible for demonstrating the relationship between environmentally acquired immune dysfunction, chronic inflammation and these diseases. Her pioneering work during a twenty year career at the National Cancer Institute includes the discovery of the modulation of DNA Methylation machinery by human retro viral infection and the development of the concept of inflammatory cytokines and chemokine signatures of infection and disease, which was first published in 1999, when Dr. Mikovits directed the Laboratory of Antiviral Drug Mechanisms in developing therapeutics and diagnostics for HIV/AIDS and AIDS associated malignancies. Therapies which are still standard of care twenty five years later and credited with saving millions of deaths from HIV/AIDS. In 2001, she moved back to industry where she directed the Cancer Biology program of EpiGenX Pharmaceuticals.  

The company focused on the development multiplex diagnostic epigenetic and proteomics expression technologies for the prediction of Immune Related Adverse Events to chemotherapy in susceptible populations. In 2006 she co-founded and developed the first neuroimmune research institute dedicated to understanding the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and related illnesses. In five short years, she won more than 6 million dollars of NIH/DOD competitive funding in grants and contracts for this program. In 2009, Drs. Ruscetti and Mikovits' labs isolated for the first time a new family of human retroviruses then identified as XMRV. In 2012 it was learned XMRV was a contaminant of the Silverman lab and the XMRVs isolated were a new human exogenous and transmissible retrovirus family, which are strongly associated with neuroimmune disease and cancer.  This new family of pathogenic human retroviruses is now called HGRV.  Dr. Mikovits has co-authored more than 50 peer reviewed publications and book chapters and the book Plague: One Scientist’s Intrepid Search for the Truth about Human Retroviruses and Chronic Fatigue Syndrome, Autism, and Other Diseases.

Dr. Judy Mikovits' site: www.plaguethebook.com 

On July 22, 2009, a special meeting was held with twenty-four leading scientists at the National Institutes of Health to discuss early findings that a newly discovered retrovirus was linked to chronic fatigue syndrome (CFS), prostate cancer, lymphoma, and eventually neurodevelopmental disorders in children.

When Dr. Judy Mikovits finished her presentation the room was silent for a moment, then one of the scientists said, “Oh my God!” The resulting investigation would be like no other in science. 

For Dr. Mikovits, a twenty-year veteran of the National Cancer Institute, this was the midpoint of a five-year journey that would start with the founding of the Whittemore-Peterson Institute for Neuro-Immune Disease at the University of Nevada, Reno, and end with her as a witness for the federal government against her former employer, Harvey Whittemore, for Illegal campaign contributions to U. S. Senate Majority Leader, Harry Reid.

On this journey Dr. Mikovits would face the scientific prejudices against CFS, wander into the minefield that is autism, and through it all struggle to maintain her faith in God and the profession to which she had dedicated her life. This is a story for anybody interested in the peril and promise of science at the very highest levels in our country."
From plaguethebook.com


The "Oh my God" moment took place at this invitation only meeting, among distinguished scientists:

QuantumJudy3.jpg2.jpg

Research Links: http://www.plaguethebook.com/really-rockin--research.html

Save Our Science! http://www.plaguethebook.com/save-our-science.html

This episode of Quantum Matrix Radio www.quantummatrixradio.com is hosted by author Pamela Senzee

QMR music is used with permission by Captain Squeegee

Fair Use Statement / Content Statement 

Watch Truth Walk: Part 1 www.qmamedia.com